MAXCYTE, INC. - Equity (MXCT)

CUSIP: 57777K106

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 6 signals
Share change
-981,364
SEC-reported price per share
$2.18
Number of holders
114
Value change
-$4,610,056
Number of buys
62
Number of sells
50
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
103,886,440

Security key

57777K106

Report period

Q2 2025

Institutions

114

Top holders

10

Ownership snapshot

Top reported holders of MXCT - MAXCYTE, INC. - Equity (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Casdin Partners Master Fu...
Disclosed value leader
Casdin Partners Master Fu...
Comparable rows
0/15
Latest evidence
31 Mar 2025
3/4/5 13F Highest disclosed value: $45,300,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Casdin Partners Master Fund, L.P. has the largest disclosed position value at $45.3M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Casdin Partners Master Fund, L.P.'s linked filing trail.
Disclosed position value Top 5
Casdin Partners Master Fund, L.P. $45.3M
CADIAN CAPITAL MANAGEMENT, LP $27.38M
BlackRock, Inc. $22.3M
MORGAN STANLEY $19.11M
VANGUARD GROUP INC $15.19M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Casdin Partners Master Fund, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$45,300,000
10,000,000 shares
— 03 Oct 2022
CADIAN CAPITAL MANAGEMENT, LP
13F
Company
13F
—
denominator unverified
$27,375,695
10,027,727 shares
— 31 Mar 2025
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$22,299,666
8,168,376 shares
— 31 Mar 2025
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$19,112,182
7,000,799 shares
— 31 Mar 2025
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$15,194,265
5,565,665 shares
— 31 Mar 2025
Vitruvian Partners LLP
13F
Company
13F
—
denominator unverified
$13,768,362
5,043,356 shares
— 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
114
Shares
71,312,542
Rows available
114
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2026 Across Filers

Q1 2026 holders
129
Q2 2025 holders
114
Holder diff
-15
Investor Q1 2026 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2026 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .